Filtered By:
Specialty: Pharmaceuticals
Education: Study
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 397 results found since Jan 2013.
CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment
IRVINE, CA – September 9, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of three devices designed to aid physicians in clot removal procedures. The announcement was made during the virtual European Society of Minimally Invasive Neurological Therapy (ESMINT).Strokes are the second leading cause of death globally, and account for an estimated 140,000 deaths in the United States each year.[i],[ii] Over half of stroke survivors become chronically disabled placing an estimated $34 billion economic burden o...
Source: Johnson and Johnson - September 9, 2020 Category: Pharmaceuticals Source Type: news
Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
RARITAN, NJ, May 25, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that all three prospective indications for milvexian, an investigational oral factor XIa (FXIa) inhibitor (being developed in collaboration with Bristol Myers Squibb), have now been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). The designations cover all three indication-seeking studies within the Phase 3 Librexia development program (Librexia STROKE, Librexia ACS and Librexia AF), which are all dosing patients. The Librexia program is unrivaled as the most comprehensive FXIa clinical...
Source: Johnson and Johnson - May 25, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Johnson & Johnson Launches Heartline ™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
New Brunswick, NJ, February 25, 2020 — Johnson & Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline™ Study, individuals must be age 65 or older...
Source: Johnson and Johnson - February 25, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
ASA: Opioid Epidemic Tied to Infection-Related Stroke
TUESDAY, Feb. 12, 2019 -- The opioid epidemic is driving a steep increase in infection-related stroke hospitalizations, according to a study published online Jan. 30 in Stroke to coincide with the American Stroke Association International Stroke...
Source: Drugs.com - Pharma News - February 12, 2019 Category: Pharmaceuticals Source Type: news
Stroke ' Alarm Clock ' Improves Acute Stroke Management Metrics
THURSDAY, Sept. 24, 2020 -- Use of a stroke alarm clock demanding active feedback significantly improves management metrics for acute stroke, according to a study published online Sept. 24 in Stroke.
Mathias Fousse, M.D., from the Saarland...
Source: Drugs.com - Pharma News - September 24, 2020 Category: Pharmaceuticals Source Type: news
Functional Stroke Recovery Varies by Age, Sex, and Stroke Type
TUESDAY, Oct. 11, 2022 -- Following stroke, long-term recovery patterns in multifaceted functional domains differ by patient age, stroke severity, and stroke type, according to a study published online Sept. 23 in JAMA Network Open.
Seyoung Shin,...
Source: Drugs.com - Pharma News - October 11, 2022 Category: Pharmaceuticals Source Type: news
Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban Study in Patients with a recent Embolic Stroke of Undetermined Source (for specialized target groups only)
Embolic stroke of undetermined source is caused by a blood clot, and affects approximately 300,000 people each year in North America and Europe / Phase III NAVIGATE ESUS study will investigate once-daily rivaroxaban for the secondary prevention of stroke in approximately 7,000 patients / Indication-seeking trial will be conducted in partnership with Population Health Research Institute and Canadian Stroke Prevention Intervention Network
Source: Bayer Company News - January 27, 2015 Category: Pharmaceuticals Source Type: news
In-Hospital Infection May Up Readmission After Stroke
THURSDAY, Nov. 8, 2018 -- For patients with ischemic stroke, infection during stroke hospitalization is associated with increased odds of 30-day readmission, according to a study published online Nov. 1 in Stroke.
Amelia K. Boehme, Ph.D., from...
Source: Drugs.com - Pharma News - November 8, 2018 Category: Pharmaceuticals Source Type: news
ASA: Flu-Like Illness Linked to Increased Risk for Stroke
WEDNESDAY, Jan. 30, 2019 -- Influenza-like illness (ILI) is associated with an increased risk for ischemic stroke and cervical artery dissection (CeAD), according to two studies presented at the American Stroke Association International Stroke...
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news
ASA: Increased Odds of Stroke, MI With E-Cigarette Use
WEDNESDAY, Jan. 30, 2019 -- Electronic cigarette use is associated with increased odds of stroke, myocardial infarction, and angina or coronary heart disease, according to a study presented at the American Stroke Association International Stroke...
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news
Stroke Patients Infrequently Screened, Treated for Bone Loss
THURSDAY, April 25, 2019 -- Patients with recent stroke are rarely screened and treated for osteoporosis, according to a study published online April 25 in Stroke.
Noting that stroke is a risk factor for subsequent osteoporosis and fractures, Eshita...
Source: Drugs.com - Pharma News - April 25, 2019 Category: Pharmaceuticals Source Type: news
Aspirin green light for brain bleed stroke patients, study finds
People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major clinical trial has found. Researchers say the findings are reassuring for the thousands of people who take the medicines to reduce their risk of heart attack and another common type of stroke caused by blood clots in the brain.
Source: World Pharma News - May 23, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Longer shifts linked to increased stroke risk
Putting in more time at work might benefit your career but could leave you at greater risk of a stroke.
A study published in the American Heart Association’s journal Stroke determined long working hours — classified as more than 10 hours daily at least 50 days out of the year — for a decade or more had a stronger link to stroke.
No differences were noted between women and men, but white col lar workers under 50 saw a strong association to stroke.
The Washington Post reports employees working…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 20, 2019 Category: Pharmaceuticals Authors: Caitlin Mullen Source Type: news
ASA: Herpes Zoster Vaccine May Reduce Risk for Stroke
WEDNESDAY, Feb. 12, 2020 -- Vaccination with zoster vaccine live (ZVL) is associated with a reduced risk for stroke among older adults, according to a study to be presented at the American Stroke Association International Stroke Conference, held...
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news
